Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 701–800 of 1,009
Lynch, A. M., Wagner, B. D., Weiss, S. J., Wall, K. M., Palestine, A. G., Mathias, M. T., Siringo, F. S., Cathcart, J. N., Patnaik, J. L., Drolet, D. W., et al. (2019) · Translational Vision Science & Technology · doi:10.1167/tvst.8.1.14 · Cited by 26
Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19Preprint
Katz, D. H., Tahir, U. A., Ngo, D., Benson, M. D., Bick, A. G., Pampana, A., Gao, Y. L., Keyes, M. J., Correa, A., Sinha, S., et al. (2020) · medRxiv · doi:10.1101/2020.06.09.20125690 · Cited by 26
SomaScan Bioinformatics: Normalization, Quality Control, and Assessment of Pre-Analytical Variation
Candia, J. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4595-6_9 · Cited by 27
The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health
Hirohama, D., Fadista, J., Ha, E., Liu, H., Abedini, A., Levinsohn, J. L., Vassalotti, A., Zeng, L., Li, C., Mohandes, S., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03872-8 · Cited by 31
Lee, J., Geiss, G. K., Demirkan, G., Vellano, C. P., Filanoski, B., Lu, Y., Ju, Z., Yu, S., Guo, H., Bogatzki, L. Y., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000291 · Cited by 24
FSBC: fast string-based clustering for HT-SELEX data
Kato, S., Ono, T., Minagawa, H., Horii, K., Shiratori, I., Waga, I., Ito, K., & Aoki, T. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03607-1 · Cited by 23
“Owing to the wide variety of possible target molecules, aptamers are commonly used for therapeutics [8], clinical diagnostics [9], the high-throughput multi-protein measurement [10], imaging [11], and biosensors [12].”
BackgroundProbert, F., Yeo, T., Zhou, Y., Sealey, M. A., Arora, S., Palace, J. A., Claridge, T. D. W., Hillenbrand, R., Oechtering, J., Leppert, D., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab084 · Cited by 27
Hong, J. M., Gibbons, M., Bashir, A., Wu, D., Shao, S. J., Cutts, Z., Chavarha, M., Chen, Y., Schiff, L., Foster, M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103586 · Cited by 23
Mookherjee, N., Ryu, M. H., Hemshekhar, M., Orach, J., Spicer, V., & Carlsten, C. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112803 · Cited by 23
Nucleic Acid Aptamers for Molecular Diagnostics and Therapeutics: Advances and Perspectives
Li, L., Xu, S., He, Y., Li, X., Yazd, H. S., Li, X., Huang, T., Cui, C., Jiang, J., & Tan, W. (2020) · Angewandte Chemie · doi:10.1002/ange.202003563 · Cited by 23
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder
Reay, W. R., Geaghan, M. P., Atkins, J., Carr, V. J., Green, M. J., & Cairns, M. J. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.07.011 · Cited by 24
Ondruš, M., Sýkorová, V., & Hocek, M. (2022) · Chemical Communications · doi:10.1039/d2cc03588j · Cited by 26
Hwang, M. C., Assassi, S., Zheng, J., Castillo, J., Chavez, R., Vanarsa, K., Mohan, C., & Reveille, J. D. (2023) · Arthritis Research & Therapy · doi:10.1186/s13075-023-03044-4 · Cited by 23
Rice, S. J., Liu, X., Miller, B., Joshi, M., Zhu, J., Caruso, C., Gilbert, C. R., Toth, J. W., Reed, M. F., Rassaei, N., et al. (2015) · PROTEOMICS · doi:10.1002/pmic.201500029 · Cited by 24
Targeting cancer cells using aptamers: cell-SELEX approach and recent advancements
Barman, J. (2015) · RSC Advances · doi:10.1039/c4ra12407c · Cited by 26
Optomechanical devices for deep plasma cancer proteomics
Kosaka, P. M., Calleja, M., & Tamayo, J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.011 · Cited by 27
Agyei, D., Acquah, C., Tan, K. X., Hii, H. K., Rajendran, S. R. C. K., Udenigwe, C. C., & Danquah, M. K. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0599-9 · Cited by 23
Han, Z., Xiao, Z., Kalantar‐Zadeh, K., Moradi, H., Shafi, T., Waikar, S. S., Quarles, L. D., Yu, Z., Tin, A., Coresh, J., et al. (2018) · Diagnostics · doi:10.3390/diagnostics8040071 · Cited by 23
Neutrophil activation in systemic capillary leak syndrome (Clarkson disease)
Xie, Z., Kuhns, D. B., Gu, X., Otu, H. H., Libermann, T. A., Gallin, J. I., Parikh, S. M., & Druey, K. M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14381 · Cited by 23
Anand, A., Chatterjee, B., Dhiman, A., Goel, R., Khan, E., Malhotra, A., Santra, V., Salvi, N. C., Khadilkar, M. V., Bhatnagar, I., et al. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113523 · Cited by 25
Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers
Cheema, A. K., Li, Y., Ventimiglia, M., Kowalczyk, K. J., Hankins, R. A., Bandi, G., Janowski, E., Grindrod, S. C., Villagra, A., & Dritschilo, A. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2340 · Cited by 23
Christopoulos, P., Harel, M., McGregor, K., Brody, Y., Puzanov, I. J., Bar, J., Elon, Y., Sela, I., Yellin, B., Lahav, C., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.23.00555 · Cited by 31
Alakwaa, F., Das, V., Majumdar, Å., Nair, V., Fermin, D., Dey, A., Slidel, T. W. F., Reilly, D. F., Myshkin, E., Duffin, K. L., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.186070 · Cited by 28
A beginners guide to SELEX and DNA aptamers
Stephens, C., Goodey, N. M., & Gubler, U. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115890 · Cited by 24
Kononenko, A., Caroprese, V., Duhoo, Y., Tekin, C., & Bastings, M. M. C. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-01939-8 · Cited by 30
Urinary Complement proteome strongly linked to diabetic kidney disease progression
Dom, Z. I. M., Moon, S., Satake, E., Hirohama, D., Palmer, N. D., Lampert, H. C., Ficociello, L., Abedini, A., Fernandez, K., Liang, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62101-5 · Cited by 28
McArdle, A., Butt, A. Q., Szentpétery, Á., de Jager, W., de Roock, S., FitzGerald, O., & Pennington, S. R. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500046 · Cited by 22
Ligand-Guided Selection with Artificially Expanded Genetic Information Systems against TCR-CD3ε
Zümrüt, H. E., Yang, Z., Williams, N. B., Arizala, J. D., Batool, S., Benner, S. A., & Mallikaratchy, P. R. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00919 · Cited by 22
Coombs, K. M. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1821656 · Cited by 25
Tsim, S., Alexander, L. E. C., Kelly, C., Shaw, A., Hinsley, S., Clark, S., Evison, M., Holme, J., Cameron, E. J., Sharma, D., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.05.018 · Cited by 24
Self-citationPlasma proteomic signature of decline in gait speed and grip strength
Liu, X., Pan, S., Xanthakis, V., Vasan, R. S., Psaty, B. M., Austin, T. R., Newman, A. B., Sanders, J. L., Wu, C., Tracy, R. P., et al. (2022) · Aging Cell · doi:10.1111/acel.13736 · Cited by 22
Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk
Dark, H. E., Paterson, C., Daya, G. N., Peng, Z., Duggan, M. R., Bilgel, M., An, Y., Moghekar, A., Davatzikos, C. A., Resnick, S. M., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26817 · Cited by 26
Gómez-Pascual, A., Naccache, T., Xu, J., Hooshmand, K., Wretlind, A., Gabrielli, M., Lombardo, M. T., Shi, L., Buckley, N. J., Tijms, B. M., et al. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108588 · Cited by 25
Autoimmune profiling with protein microarrays in clinical applications
Abel, L., Kutschki, S., Turewicz, M., Eisenacher, M., Stoutjesdijk, J., Meyer, H. E., Woitalla, D., & May, C. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.02.023 · Cited by 28
Begić, E., Hadžidedić, S., Kulaglić, A., Ramić-Brkić, B., Begić, Z., & Čaušević, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212261 · Cited by 25
MacDonald, A., Priess, M., Curran, J., Guess, J. R., Farutin, V., Oosterom, I., Chu, C. L., Cochran, E. D., Zhang, L., Getchell, K. M., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0417 · Cited by 25
Butler, A. E., Nandakumar, M., Sathyapalan, T., Brennan, E., & Atkin, S. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010321 · Cited by 25
A standardized framework for circulating blood proteomics
Cai, X., Geyer, P. E., Pérez‐Riverol, Y., Omenn, G. S., Dong, L., Winkler, R., Ahadi, S., Lössl, P., Yu, X., Chang, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02319-7 · Cited by 22
Larson, A., Libermann, T. A., Bowditch, H. K., Das, G., Diakos, N., Huggins, G. S., Rastegar, H., Chen, F. Y., Rowin, E. J., Maron, M. S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052474 · Cited by 20
Connecting the epigenome, metabolome and proteome for a deeper understanding of disease
Suhre, K., & Zaghlool, S. B. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13306 · Cited by 26
Suzuki, M., Cole, J., Konno, S., Makita, H., Kimura, H., Nishimura, M., & Maciewicz, R. A. (2021) · Clinical and Translational Allergy · doi:10.1002/clt2.12091 · Cited by 21
Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus
Stacey, D., Chen, L., Stanczyk, P. J., Howson, J. M. M., Mason, A. M., Burgess, S., MacDonald, S. G., Langdown, J., McKinney, H., Downes, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28729-3 · Cited by 25
Self-citationWang, L., Western, D., Timsina, J., Repaci, C., Song, W., Norton, J. B., Kohlfeld, P., Budde, J., Climer, S., Butt, O. H., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106408 · Cited by 23
Kuprikova, N. M., Ondruš, M., Bednářová, L., Riopedre-Fernández, M., Slavětínská, L. P., Sýkorová, V., & Hocek, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad893 · Cited by 22
Harnessing the power of proteomics in precision diabetes medicine
Kurgan, N., Larsen, J. K., & Deshmukh, A. S. (2024) · Diabetologia · doi:10.1007/s00125-024-06097-5 · Cited by 24
Quantitative and sensitive protein detection strategies based on aptamers
Yoshida, Y., Waga, I., & Horii, K. (2012) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201200037 · Cited by 21
Park, N. J., Wang, X., Diaz, A., Goos, D. M., Bock, C., Vaught, J. D., Sun, W., & Strom, C. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071703 · Cited by 21
Self-citationAn Evaluation of an Aptamer for Use as an Affinity Reagent with MS: PCSK9 as an Example Protein
Gupta, V., Lassman, M. E., McAvoy, T., Lee, A. Y., Chappell, D. L., & Laterza, O. (2016) · Bioanalysis · doi:10.4155/bio-2016-0046 · Cited by 21
Aptamer-based diagnostic and therapeutic approaches in animals: Current potential and challenges
Devi, S., Sharma, N., Ahmed, T., Huma, Z. I., Kour, S., Sahoo, B., Singh, A. K., Mačešić, N., Lee, S., & Gupta, M. K. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.05.031 · Cited by 21
Evolving A RIG-I Antagonist: A Modified DNA Aptamer Mimics Viral RNA
Ren, X., Gelinas, A. D., Linehan, M. M., Iwasaki, A., Wang, W., Janjić, N., & Pyle, A. M. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167227 · Cited by 23
Patel-Murray, N. L., Zhang, L., Claggett, B. L., Xu, D., Serrano‐Fernández, P., Healey, M. L., Wandel, S., Chen, C., Jacob, J., Xu, H., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.033544 · Cited by 23
Fluorescent labeling strategies for molecular bioimaging
Streit, M., Budiarta, M., Jungblut, M., & Beliu, G. (2025) · Biophysical Reports · doi:10.1016/j.bpr.2025.100200 · Cited by 42
Systematic evaluation of blood contamination in nanoparticle-based plasma proteomics
Gao, H., Zhan, Y., Liu, Y., Zhu, Z., Zheng, Y., Qian, L., Xue, Z., Cheng, H., Nie, Z., Ge, W., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00346-9 · Cited by 29
Development of ssDNA aptamers for the capture and detection of Salmonella typhimurium
Moon, J.-H., Kim, G., & Park, S. (2014) · Analytical Methods · doi:10.1039/c4ay01035c · Cited by 20
Impact of multi-micronutrient supplementation on lipidemia of children and adolescents
Chakrabarti, A., Eiden, M., Morin‐Rivron, D., Christinat, N., Monteiro, J. P., Kaput, J., & Masoodi, M. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.09.010 · Cited by 22
Frank, B. S., Khailova, L. S., Silveira, L. J., Mitchell, M. B., Morgan, G. J., Hsieh, E. W. Y., Maria, M. V. D., Twite, M. D., Klawitter, J., & Davidson, J. A. (2020) · Translational research · doi:10.1016/j.trsl.2020.10.001 · Cited by 21
Replication study of plasma proteins relating to Alzheimer's pathology
Shi, L., Winchester, L. M., Westwood, S., Baird, A. L., Anand, S. N., Buckley, N. J., Hye, A., Ashton, N. J., Bos, I., Vos, S. J. B., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12322 · Cited by 20
Advances in aptamer-based sensing assays for C-reactive protein
Tang, M.-Q., Xie, J., Rao, L., Kan, Y.-J., Luo, P., & Qing, L. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03674-0 · Cited by 23
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans
Ferrannini, E., Manca, M. L., Ferrannini, G., Andreotti, F., Andreini, D., Latini, R., Magnoni, M., Williams, S. A., Maseri, A., & Maggioni, A. P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.790289 · Cited by 22
Bioinformatics tools and data resources for assay development of fluid protein biomarkers
Waury, K., Willemse, E. A. J., Vanmechelen, E., Zetterberg, H., Teunissen, C. E., & Abeln, S. (2022) · Biomarker Research · doi:10.1186/s40364-022-00425-w · Cited by 23
Aptamer-functionalized liposomes for targeted cancer therapy
Moosavian, S. A., Kesharwani, P., Singh, V., & Sahebkar, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85881-6.00014-2 · Cited by 26
MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study
Buckley, L. F., Agha, A. M., Dorbala, P., Claggett, B. L., Yu, B., Hussain, A., Nambi, V., Chen, L. Y., Matsushita, K., Hoogeveen, R. C., et al. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010849 · Cited by 28
de Bakker, M., Petersen, T. B., Rueten‐Budde, A. J., Akkerhuis, K. M., Umans, V. A. W. M., Brugts, J. J., Germans, T., Reinders, M. J. T., Katsikis, P. D., van der Spek, P. J., et al. (2023) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztad056 · Cited by 20
Self-citationAptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development
Wang, B., Kobeissy, F. H., Golpich, M., Cai, G., Li, X., Abedi, R., Haskins, W. E., Tan, W., Benner, S. A., & Wang, K. (2024) · Molecules · doi:10.3390/molecules29051124 · Cited by 31
Molecular tools for companion diagnostics
Zieba, A., Grannas, K., Söderberg, O., Gullberg, M. T., Nilsson, M. F., & Landegren, U. D. (2012) · New Biotechnology · doi:10.1016/j.nbt.2012.05.004 · Cited by 25
Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model
Kato, B. S., Nicholson, G., Neiman, M., Rantalainen, M., Holmes, C. C., Barrett, A., Uhlén, M., Nilsson, P., Spector, T. D., & Schwenk, J. M. (2011) · Proteome Science · doi:10.1186/1477-5956-9-73 · Cited by 24
Diffuse lung disease in children: Summary of a scientific conference
Hamvas, A., Deterding, R. R., Balch, W. E., Schwartz, D. A., Albertine, K. H., Whitsett, J. A., Cardoso, W. V., Kotton, D. N., Kourembanas, S., & Hagood, J. S. (2013) · Pediatric Pulmonology · doi:10.1002/ppul.22805 · Cited by 20
Yu, L., Sun, J., Daniels, J. R., Cao, Z., Schnackenberg, L. K., Choudhury, D., Palevsky, P. M., Ma, J. Z., Beger, R. D., & Portilla, D. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.04.012 · Cited by 20
Desai, V. G., Lee, T., Moland, C. L., Vijay, V., Han, T., Lewis, S. M., Herman, E. H., & Fuscoe, J. C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.016 · Cited by 22
An immune signature of postoperative cognitive decline: a prospective cohort study
Verdonk, F., Cambriel, A. I. F., Hedou, J. J., Ganio, E. A., Bellan, G., Gaudilliere, D. K., Einhaus, J. F., Sabayev, M., Stelzer, I. A., Feyaerts, D., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002118 · Cited by 21
A method for selecting modified DNAzymes without the use of modified DNA as a template in PCR
Renders, M., Miller, E., Hollenstein, M., & Perrin, D. M. (2015) · Chemical Communications · doi:10.1039/c4cc07588a · Cited by 19
Sexual Dimorphism, Age, and Fat Mass Are Key Phenotypic Drivers of Proteomic Signatures
Curran, A. M., Draper, C. F., Scott‐Boyer, M., Valsesia, A., Roche, H. M., Ryan, M. F., Gibney, M. J., Kutmon, M., Evelo, C. T., Coort, S. L., et al. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00501 · Cited by 24
Side chain determinants of biopolymer function during selection and replication
Lichtor, P. A., Chen, Z., Elowe, N. H., Chen, J. C., & Liu, D. R. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0229-2 · Cited by 20
Increased Levels of Coagulation Factor XI in Plasma Are Related to Alzheimer’s Disease Diagnosis
Begić, E., Hadžidedić, S., Obradovic, S. D., Begić, Z., & Čaušević, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200358 · Cited by 21
Jackson, H., Menikou, S., Hamilton, S., McArdle, A. J., Shimizu, C., Galassini, R., Huang, H., Kim, J., Tremoulet, A. H., Thorne, A. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115655 · Cited by 19
Yu, H., Alkhamis, O., Canoura, J., Liu, Y., & Xiao, Y. (2021) · Angewandte Chemie · doi:10.1002/ange.202008663 · Cited by 26
Perspective—The Feasibility of Continuous Protein Monitoring in Interstitial Fluid
Young, T., Clark, V., Arroyo‐Currás, N., & Heikenfeld, J. C. (2023) · ECS Sensors Plus · doi:10.1149/2754-2726/accd7e · Cited by 20
Mahoney, S. A., Dey, A. K., Basisty, N., & Herman, A. B. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00352.2023 · Cited by 21
Plasma proteomics of acute tubular injury
Schmidt, I. M., Surapaneni, A., Zhao, R., Upadhyay, D., Yeo, W.-J., Schlosser, P., Huynh, C., Srivastava, A., Pálsson, R., Kim, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51304-x · Cited by 27
Recent Advances in Biocatalytic and Chemoenzymatic Synthesis of Oligonucleotides
Bizat, P. N., Sabat, N., & Hollenstein, M. (2025) · ChemBioChem · doi:10.1002/cbic.202400987 · Cited by 29
Selective Targeting to Glioma with Nucleic Acid Aptamers
Aptekar, S., Arora, M., Lawrence, C. L., Lea, R. W., Ashton, K. M., Dawson, T., Alder, J. E., & Shaw, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134957 · Cited by 19
Engineered Aptamers to Probe Molecular Interactions on the Cell Surface
Batool, S., Bhandari, S., George, S., Okeoma, P., Van, N. A., Zümrüt, H. E., & Mallikaratchy, P. R. (2017) · Biomedicines · doi:10.3390/biomedicines5030054 · Cited by 19
Standardized Immunomonitoring: Separating the Signals from the Noise
Duffy, D. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.06.002 · Cited by 21
Wakui, K., Abe, A., Yoshitomi, T., Furusho, H., & Yoshimoto, K. (2019) · Analytical Sciences · doi:10.2116/analsci.18sdn04 · Cited by 19
Minagawa, H., Kataoka, Y., Fujita, H., Kuwahara, M., Horii, K., Shiratori, I., & Waga, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082683 · Cited by 19
Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D
Hoppe, J. E., Wagner, B. D., Harris, J. K., Rowe, S. M., Heltshe, S. L., DeBoer, E. M., & Sagel, S. D. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2022.03.012 · Cited by 21
Strategies for biomarker discovery in fibrotic disease
Marshall, R. P., Simpson, J. K., & Lukey, P. T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.018 · Cited by 23
Hjelm, B., Forsström, B., Löfblom, J., Rockberg, J., & Uhlén, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045817 · Cited by 19
Implementation of Proteomics for Cancer Research: Past, Present, and Future
Karimi, P., Shahrokni, A., & Ranjbar, M. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.6.2433 · Cited by 21
Synthesis of chemically modified DNA
Shivalingam, A., & Brown, T. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160051 · Cited by 21
DeBoer, E. M., Kroehl, M., Wagner, B. D., Accurso, F. J., Harris, J. K., Lynch, D. A., Sagel, S. D., & Deterding, R. R. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600147 · Cited by 18
Metabolic and proteomic signatures of hypoglycaemia in type 2 diabetes
Halama, A., Kahal, H., Bhagwat, A. M., Zierer, J., Sathyapalan, T., Graumann, J., Suhre, K., & Atkin, S. L. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13602 · Cited by 20
Advances in point-of-care testing for cardiovascular diseases
Regan, B., O’Kennedy, R. J., & Collins, D. A. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.09.001 · Cited by 19
Probert, F., Yeo, T., Zhou, Y., Sealey, M. A., Arora, S., Palace, J. A., Claridge, T. D. W., Hillenbrand, R., Oechtering, J., Kühle, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.811351 · Cited by 21
Rashid, M., Lorzadeh, S., Gao, A., Ghavami, S., & Coombs, K. M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166617 · Cited by 24
Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents
Gelinas, A. D., Tan, T. K., Liu, S., Gilbert‐Jaramillo, J., Chadwick, J., Harding, A. C., Zhang, C., Ream, B. E., Chase, C. N., Otis, M. R., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.008 · Cited by 20
Self-citationKim, H., Lichtenstein, A. H., Ganz, P., Du, S., Tang, O., Yu, B., Chatterjee, N., Appel, L. J., Coresh, J., & Rebholz, C. M. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028821 · Cited by 20
Kinetic capillary electrophoresis in screening oligonucleotide libraries for protein binders
Le, A. T. H., Krylova, S. M., & Krylov, S. N. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117061 · Cited by 18
Gedik, H., Nguyen, T. H., Peterson, R. E., Chatzinakos, C., Riley, B. P., Vladimirov, V. I., & Bacanu, S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1191264 · Cited by 17
Cardner, M., Tuckwell, D. S., Kostikova, A., Forrer, P., Siegel, R. M., Marti, A., Vandemeulebroecke, M., & Ferrero, E. (2023) · RMD Open · doi:10.1136/rmdopen-2023-003042 · Cited by 18
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.